Table 1. Associations between patient characteristics and ORAOV1 gene amplification (n = 94).
| Patients characteristics | ORAOV1 | P-values | |
|---|---|---|---|
| Amp (−) | Amp (+) | ||
| Number | 45 | 49 | |
| Age (years) | |||
| <70 | 33 | 34 | 0.82 |
| >70 | 12 | 15 | |
| Sex | |||
| Male | 39 | 43 | 1.00 |
| Female | 6 | 6 | |
| Location | |||
| Ut or Mt | 20 | 35 | 0.012* |
| Lt or Ae | 25 | 14 | |
| Tumor differentiation | |||
| Well or moderate | 41 | 36 | 0.033* |
| Poor | 4 | 13 | |
| pStage | |||
| IIIA | 17 | 26 | 0.15 |
| IIIB or IIIC | 28 | 23 | |
| Lymphatic invasion | |||
| 0 | 9 | 8 | 0.79 |
| 1 or 2 | 36 | 41 | |
| Vascular invasion | |||
| 0 | 33 | 38 | 0.81 |
| 1 | 12 | 11 | |
| Residual cancer | |||
| 0 | 7 | 5 | 0.54 |
| 1 or 2 | 38 | 44 | |
Abbreviations: Amp, amplification; Ut, upper thoracic esophagus; Mt, middle thoracic esophagus; Lt, lower thoracic esophagus; Ae, abdominal esophagus.